The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of a novel c-MET based circulating tumor cell (CTC) biomarker in patients with gastrointestinal (GI) and genitourinary (GU) malignancies.
 
Tian Zhang
No Relationships to Disclose
 
Rengasamy Boominathan
Employment - Janssen Research & Development
 
Brad Foulk
Employment - Janssen Research & Development
 
Mark Carle Connelly
Employment - Janssen Research & Development
 
Chandra Rao
Employment - Janssen Research & Development
 
Gabor Kemeny
No Relationships to Disclose
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer/Onyx; Celgene; Marval Biosciences; Onyx
Research Funding - Abbvie (Inst); ArQule (Inst); Bayer (Inst); Eisai (Inst); Exelixis (Inst); Gilead Sciences (Inst); Lilly (Inst); MethylGene (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
James L. Abbruzzese
Stock and Other Ownership Interests - Jennerex; Pharmacyclics
Honoraria - Aduro Biotech; Bristol-Myers Squibb; Clarion Healthcare Consulting; Daiichi Sankyo; Halozyme; Merck Sharp & Dohme
Consulting or Advisory Role - Acerta Pharma; Aduro Biotech; Bristol-Myers Squibb; Celgene; Clarion Healthcare Consulting; Daiichi Sankyo; Genekey; Halozyme; Merck Sharp & Dohme; Progen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Daiichi Sankyo; Merck Sharp & Dohme
 
Michael Roger Harrison
Honoraria - Dendreon; Novartis; Prometheus
Consulting or Advisory Role - AVEO; Bayer; Dendreon; Exelixis; Novartis; Sanofi
Research Funding - Argos Therapeutics; Bristol-Myers Squibb; Exelixis; Janssen Research & Development; Medivation; Pfizer
 
Daniel J. George
Honoraria - Algeta ASA; Amgen; Astellas Pharma; AVEO; Dendreon; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Algeta ASA; Astellas Pharma; Aveo; Bayer; BIND Biosciences; Dendreon; Exelixis; GlaxoSmithKline; Medivation; Novartis; Pfizer; progenics; Sanofi; Viamet Pharmaceuticals
Speakers' Bureau - Dendreon; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Progenics (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Algeta/Bayer; Astellas Pharma; AVEO; Bristol-Myers Squibb; Dendreon; Pfizer; Progenics; Sanofi
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; Regeneron; Sanofi; TRACON Pharma
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); TRACON Pharma (Inst)
 
Mariano A. Garcia-Blanco
Research Funding - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - n/a
Other Relationship - Metastat
 
Andrew J. Armstrong
Honoraria - Dendreon; Pfizer; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Dendreon; Janssen; Medivation/Astellas; Sanofi
Research Funding - Active Biotech; Dendreon; Ipsen; Janssen; Medivation; Novartis; Pfizer; Sanofi